Evidence map›Paper›PMID 41394105›Full record

ArticleFrontiers in cellular and infection microbiology2025

Molecular, biofilm and motility characterization of

Zelin Yu, Hongbo Fu, Yanqiong Zhou, Xiajiong Luo, Yuebin Wu, Zejian Kuang, Danwei Cai, Xiuming Wu, Xiaobing Hong

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Redefining Antimicrobial Resistance inInternational journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zelin Yu *Department of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Hongbo Fu *Department of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Yanqiong ZhouDepartment of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xiajiong LuoDepartment of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Yuebin WuDepartment of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Zejian KuangDepartment of Critical Care Medicine, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Danwei CaiDepartment of Critical Care Medicine, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xiuming WuDepartment of Critical Care Medicine, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xiaobing HongDepartment of Pharmacy, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multidrug-resistant Methods: Following an outbreak in March-April 2024, 21 A Results: All 21 A Conclusion: This NICU outbreak was driven by CRAB ST195 harboring a conserved resistome. Strain-specific differences in biofilm formation and motility under antibiotic stress highlight the interplay between genetic lineage and phenotypic adaptability. Levofloxacin demonstrates dual anti-biofilm and anti-motility effects, which could guide targeted infection control strategies against high-risk

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBiofilmsIntensive Care Units, NeonatalAnti-Bacterial AgentsCarbapenemsChinaCross InfectionDisease OutbreaksDrug Resistance, Multiple, BacterialHospitals, PediatricHumansInfant, NewbornLevofloxacinMicrobial Sensitivity TestsMultilocus Sequence TypingAnti-Bacterial AgentsCarbapenemsLevofloxacinAcinetobacter baumanniibiofilmchildrenmotilitymultidrug resistance

Identifiers

PMID41394105
PMCPMC12698599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.